UBS AM’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Buy |
158,439
+54,333
| +52% | +$1.35M | ﹤0.01% | 1820 |
|
|
2025
Q1 | $3.23M | Sell |
104,106
-552
| -0.5% | -$17.1K | ﹤0.01% | 1779 |
|
|
2024
Q4 | $3.3M | Buy |
104,658
+14,138
| +16% | +$446K | ﹤0.01% | 1807 |
|
|
2024
Q3 | $5.24M | Buy |
90,520
+2,778
| +3% | +$161K | ﹤0.01% | 1543 |
|
|
2024
Q2 | $3.56M | Buy |
87,742
+36,934
| +73% | +$1.5M | ﹤0.01% | 1685 |
|
|
2024
Q1 | $2.13M | Hold |
50,808
| – | – | ﹤0.01% | 1664 |
|
|
2023
Q4 | $1.95M | Buy |
50,808
+3,807
| +8% | +$146K | ﹤0.01% | 1705 |
|
|
2023
Q3 | $1.45M | Buy |
47,001
+1,914
| +4% | +$59K | ﹤0.01% | 1773 |
|
|
2023
Q2 | $1.64M | Hold |
45,087
| – | – | ﹤0.01% | 1765 |
|
|
2023
Q1 | $1.64M | Buy |
45,087
+1,698
| +4% | +$61.9K | ﹤0.01% | 1765 |
|
|
2022
Q4 | $1.28M | Buy |
43,389
+5,790
| +15% | +$171K | ﹤0.01% | 1728 |
|
|
2022
Q3 | $1.47M | Sell |
37,599
-4,028
| -10% | -$157K | ﹤0.01% | 1756 |
|
|
2022
Q2 | $1.61M | Buy |
41,627
+3,550
| +9% | +$137K | ﹤0.01% | 1719 |
|
|
2022
Q1 | $1.85M | Buy |
38,077
+597
| +2% | +$28.9K | ﹤0.01% | 1830 |
|
|
2021
Q4 | $2.75M | Buy |
37,480
+12,375
| +49% | +$909K | ﹤0.01% | 1720 |
|
|
2021
Q3 | $2.29M | Buy |
25,105
+3,624
| +17% | +$330K | ﹤0.01% | 1776 |
|
|
2021
Q2 | $1.35M | Sell |
21,481
-3,400
| -14% | -$214K | ﹤0.01% | 2037 |
|
|
2021
Q1 | $674K | Buy |
24,881
+9,300
| +60% | +$252K | ﹤0.01% | 2275 |
|
|
2020
Q4 | $285K | Buy |
15,581
+3,400
| +28% | +$62.1K | ﹤0.01% | 2425 |
|
|
2020
Q3 | $219K | Hold |
12,181
| – | – | ﹤0.01% | 2385 |
|
|
2020
Q2 | $201K | Sell |
12,181
-1,500
| -11% | -$24.8K | ﹤0.01% | 2386 |
|
|
2020
Q1 | $177K | Buy |
13,681
+1,201
| +10% | +$15.5K | ﹤0.01% | 2309 |
|
|
2019
Q4 | $230K | Buy |
+12,480
| New | +$230K | ﹤0.01% | 2443 |
|